The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-ethylbenzyloxy)-N-(pyridin-3-yl)benzamide ID: ALA4540510
Cas Number: 1883528-69-5
PubChem CID: 118911741
Product Number: L647031, Order Now?
Max Phase: Preclinical
Molecular Formula: C21H20N2O2
Molecular Weight: 332.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCc1ccccc1COc1ccccc1C(=O)Nc1cccnc1
Standard InChI: InChI=1S/C21H20N2O2/c1-2-16-8-3-4-9-17(16)15-25-20-12-6-5-11-19(20)21(24)23-18-10-7-13-22-14-18/h3-14H,2,15H2,1H3,(H,23,24)
Standard InChI Key: YRUSTWBJNUPPQI-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
34.7003 -10.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6992 -11.7360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4072 -12.1450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1169 -11.7355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1141 -10.9129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4054 -10.5076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8202 -10.5016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5295 -10.9075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8171 -9.6844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.2356 -10.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8252 -12.1430 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.8265 -12.9602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5349 -13.3677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5315 -14.1822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2391 -14.5896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9471 -14.1799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9432 -13.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2351 -12.9548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8232 -14.5898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1161 -14.1802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9433 -10.9056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6490 -10.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6463 -9.6770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9321 -9.2712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.2294 -9.6841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
14 19 1 0
19 20 1 0
10 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 10 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 332.40Molecular Weight (Monoisotopic): 332.1525AlogP: 4.48#Rotatable Bonds: 6Polar Surface Area: 51.22Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.37CX LogP: 4.37CX LogD: 4.37Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.72Np Likeness Score: -1.46
References 1. Li Y, Huang T, Lou B, Ye D, Qi X, Li X, Hu S, Ding T, Chen Y, Cao Y, Mo M, Dong J, Wei M, Chu Y, Li H, Jiang XC, Cheng N, Zhou L.. (2019) Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor., 163 [PMID:30580239 ] [10.1016/j.ejmech.2018.12.028 ]